Minalrestat(129688-50-2)
- Name: Minalrestat
- Synonyms:ARI 509;Minalrestat; WAY-ARI 509
- Molecular Formula:C19H11 Br F2 N2 O4
- Molecular Weight:449.208
- CAS Registry Number:129688-50-2
- EINECS:
- Melting Point:231-232℃
- Water Solubility:
CAS No.129688-50-2 Minalrestat
Assay:98% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:Minalrestat is an aldose reductase inhibitor originated by Wyeth. In Aug 2002, Phase-III for Diabetic retinopathy was discontinued in USA and Europe.
Min. Order:0
Supplier:BOC Sciences [ United States]
Premium
SupplierTel:1-631-485-4226
Address:Ramsey Road
- Contact Suppliers
Other Product
- 179733-12-1/Koniamide A
- 71230-72-3/2,5-dimethoxy-4-pyrrolidin-1-ylbenzenediazonium hexafluorophosphate
- 100078-99-7/9-(4-chlorophenyl)-4-phenyl-1,2,7,8-tetrazabicyclo[4.3.0]nona-2,4,6,8- tetraene
- 5423-54-1/4-Hydroxy-1,5-naphthyridine
- 148770-78-9/major histocompatibility complex-binding protein 2
- 1125-34-4/6-carboxy-2-methyl-1-oxo-1,2-dihydropyridinium
- 136363-39-8/Nika protein
- 68915-82-2/Linseed oil, polymer with formaldehyde and 4-(1,1,3,3-tetramethylbutyl)phenol
- 78371-69-4/Oxaine M
- 28772-56-7/Bromadiolone
- 5670-04-2/ethyl (2Z)-5-(3,4-dimethoxyphenyl)-2-({3-ethoxy-4-[(4-nitrobenzyl)oxy]phenyl}methylidene)-7-methyl-3-oxo-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
- 154371-13-8/2-[(4-ethylphenyl)amino]-4H-[1,3]thiazino[5,6-b]quinoxalin-4-one
- 57944-39-5/1A,1B-DIHOMO PROSTAGLANDIN F2ALPHA
- 74686-86-5/4-azido-alpha-diazoacetophenone
- 73758-50-6/3-Hydroxy-N-(α-methyl-m-trifluoromethylphenethyl)butyramide
- 319-94-8/GAMMA-PENTACHLOROCYCLOHEXENE
- 90170-23-3/Acetamide, N-(2-amino-4-nitrophenyl)-, reaction products with 4-aminophenol, cyanoguanidine, p-phenylenediamine and sodium sulfide
- 30507-21-2/2-[2-(4-methoxyphenyl)ethenyl]quinazolin-4(1H)-one
- 129688-50-2/Minalrestat
- 68814-27-7/Soybean oil, polymer with adipic acid, glycerol and phthalic anhydride
- 5250-17-9/(2E)-1-(5-chloro-2-hydroxyphenyl)-3-pyridin-2-ylprop-2-en-1-one
- 20336-15-6/2,4,6-TRI-TERT-BUTYLPYRIDINE
- 137442-16-1/L-alpha-aspartyl-(betaR)-beta-methyl-L-tyrosyl-L-phenylalanylglycyl-L-tryptophyl-N-methyl-L-norleucyl-L-alpha-aspartyl-L-phenylalaninamide
- 107132-15-0/ddAMP
- 66974-94-5/4-[(1E)-3,3-dimethyltriaz-1-en-1-yl]benzene-1,3-dicarboxamide
- 7388-03-6/(1R)-1-(4-nitrophenyl)-2-(propan-2-ylamino)ethanol hydrochloride (1:1)
- 5329-46-4/1,1-bis(ethylsulfanyl)-5-(trityloxy)pentane-2,3,4-triyl triacetate (non-preferred name)
- 75102-66-8/(Z)-2-Methyl-2-butenoic acid [(3aR,4S,5R,6S,8S,10R,11S,11aR)-dodecahydro-5,10-dihydroxy-6,10-dimethyl-3-methylene-11-[(R)-2-methyl-1-oxobutoxy]-2-oxo-5,8-epoxycyclodeca[b]furan-4-yl] ester
- 16584-05-7/1-Ethyl-1H-benzotriazole
- 61809-81-2/benzene-1,3-dicarboxylic acid; 6-(3-hydroxy-2,2-dimethyl-propoxy)-6-oxo-hexanoic acid; propane-1,2-diol